Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Orphanet Journal of Rare Diseases|March 12, 2016
Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugsKatarzyna Kolasa, Krzysztof M Zwolinski, Zoltan Kalo, et al.
Health Policy (Amsterdam, Netherlands)|December 3, 2014
The paradox of public participation in the healthcare in Poland--what citizens want, and what they thinkKatarzyna Kolasa, Jacek Dohnalik, Ewa Borek, et al.
Roczniki Panstwowego Zakladu Higieny|September 28, 2022
An evaluation of the knowledge on specific nutritional needs and factors affecting pregnancy outcome in women of reproductive ageJulianna Kostecka, Monika Bojanowska, Joanna Kostecka-Jarecka, et al.
Orphanet Journal of Rare Diseases|April 29, 2018
Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysisKatarzyna Kolasa, Krzysztof Miroslaw Zwolinski, Vladimir Zah, et al.
JMIR Mhealth and Uhealth|May 25, 2021
State of the Art in Adoption of Contact Tracing Apps and Recommendations Regarding Privacy Protection and Public Health: Systematic ReviewKatarzyna Kolasa, Francesca Mazzi, Ewa Leszczuk-Czubkowska, et al.
Pharmacoeconomics|June 9, 2020
Future of Data Analytics in the Era of the General Data Protection Regulation in EuropeKatarzyna Kolasa, W Ken Redekop, Alexander Berler, et al.
Tomography (Ann Arbor, Mich.)|April 27, 2023
Do We Need Another CT Scanner?-The Pilot Study of the Adoption of an Evolutionary Algorithm to Investment Decision Making in HealthcareKatarzyna Kolasa, Grzegorz Kozinski, Maria Wisniewska, et al.
Diabetes Technology & Therapeutics|November 10, 2011
The cost-effectiveness of saxagliptin versus NPH insulin when used in combination with other oral antidiabetes agents in the treatment of type 2 diabetes mellitus in PolandWladyslaw Grzeszczak, Leszek Czupryniak, Katarzyna Kolasa, et al.
Health Policy (Amsterdam, Netherlands)|June 24, 2025
Shall we call for a doctor? How to build trust toward AI in healthcare: Insights from a Polish cross-sectional preference studyKatarzyna Kolasa, Katarzyna Baliga-Nicholson, Jaroslaw Wasniewski, et al.
Przeglad Epidemiologiczny|July 9, 2011
[Cost of lost productivity in pharmacoeconomics analysis. Part II. Survey in the expert group]Witold Wrona, Tomasz Hermanowski, Michał Jakubczyk, et al.
Pageof 5